What is Brellium?
Headquartered in New York, New York, Brellium operates at the intersection of artificial intelligence and healthcare compliance. The company's core offering is an automated chart review and compliance auditing software designed to help healthcare providers meet payor and clinical quality standards without increasing manual workloads. By leveraging AI, Brellium proactively identifies documentation errors and compliance risks, integrating seamlessly with electronic medical record systems to provide real-time feedback and correction guidance to clinical teams. The platform supports prebuilt and customizable compliance frameworks, offering advanced capabilities in AI-driven evaluation and management coding, medical decision making coding, ICD-10 coding, medication management review, incident reporting, and audit intelligence.
How much funding has Brellium raised?
Brellium has raised a total of $13.7M across 1 funding round:
Series A
$13.7M
Series A (2025): $13.7M with participation from Menlo Ventures, Necessary Ventures, Fiat Ventures, First Round Capital, Left Lane Capital, and Dhvp
Key Investors in Brellium
Menlo Ventures
Menlo Ventures is a venture capital firm based in Menlo Park, specializing in early and growth-stage technology companies across various sectors, including enterprise software and frontier tech.
Necessary Ventures
Necessary Ventures is a venture capital firm that invests across a wide range of sectors and stages, from pre-seed to pre-IPO, focusing on empowering founders with resources and strategic guidance.
Fiat Ventures
Fiat Ventures is an early-stage venture capital firm focused on the Fintech sector, leveraging its network to provide hands-on support and growth consulting to entrepreneurs.
What's next for Brellium?
The substantial enterprise-level funding secured by Brellium signals a pivotal growth phase for the company. This capital infusion is expected to accelerate the development and deployment of its AI-driven compliance solutions, enabling broader market penetration within the healthcare sector. The strategic investment will likely fuel enhancements to the platform's AI capabilities, expand its integration with diverse EMR systems, and bolster its sales and marketing efforts to reach more healthcare providers. Brellium's focus on automating complex compliance processes positions it to address critical pain points in healthcare, suggesting a trajectory towards becoming a leading provider of clinical compliance technology.
See full Brellium company page
